Protagonist Therapeutics, Inc.

US$132.04As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PTGXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 21.47%
Div yield —
ROE 39.56%
Biotechnology
Beta (5Y) 1.22
PE TTM 26.80
TSR TTM 67.95%
Mkt cap US$8.618B
ROIC 174.60%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$159
20.27%
(7.34%)
Hold 10|7|8|3|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.51
1.57
1.54
1.70
3.96%
13.69%
9.26%
21.86%
Revenue$M
452.7
475.6
486.3
475.7
13.32%
12.47%
11.70%
9.13%
Peers (US$8.618B)
Cap (US$)
PE
8.916B
40.87x
8.486B
21.61x
Capital
TTM
5Y
10Y
Leveragex
1.065
(0.101)
(0.104)
EBIT/Intx
4.445
0.154
0.167
Own earn%
263.44
(38.81)
(35.88)
Sh yield%
38.31
50.96
46.04
Owners
Insiders/Inst%
2.90
84.00
Short interest%
5.63
SBC / revenue%
2.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
26–32
$1 testx
−0.1
Incr. ROIC%
1